Foundayo 2.5 mg: What Happens After the Starting Dose?

After completing the first month on Foundayo 0.8 mg, the next stage of the standard licensed dosing schedule is Foundayo 2.5 mg once daily.

For many patients, this is the point where treatment begins to feel more established.

But what should you expect from Foundayo 2.5 mg? How long do you stay on it? And what happens if you are not yet ready to increase?

When do you move to Foundayo 2.5 mg?

The licensed Foundayo dosing schedule starts at 0.8 mg once daily.

After 30 days, the dose should increase to 2.5 mg once daily.

Patients should then remain on 2.5 mg for at least another 30 days before moving to the next strength, 5.5 mg, where clinically appropriate.

The gradual increase is designed to help your body adjust to orforglipron and reduce the risk of gastrointestinal side effects.

What should I expect on Foundayo 2.5 mg?

Every patient responds differently.

Compared with the introductory 0.8 mg dose, some people may begin to notice a clearer effect on:

• hunger
• appetite
• portion sizes
• feelings of fullness
• food cravings or food noise

Others may still experience only subtle changes at this stage.

It is important not to compare your progress too closely with another patient. Foundayo is gradually titrated, and your response is assessed over time rather than based on one particular week.

Is Foundayo 2.5 mg a maintenance dose?

Under the standard licensed pathway, 2.5 mg remains part of the initial dose-escalation schedule.

After at least 30 days on 2.5 mg, treatment can progress to 5.5 mg once daily.

However, that does not mean that a patient struggling with side effects should simply increase regardless.

If you are experiencing significant nausea, vomiting, diarrhoea, constipation or difficulty maintaining adequate food and fluid intake, speak to one of our clinicians before changing dose.

Why can't I increase sooner than 30 days?

The 30-day interval gives your body time to adapt.

Foundayo works on GLP-1 receptors and can affect appetite and gastrointestinal function. Increasing too quickly may make digestive side effects more difficult to tolerate.

The UK product information therefore specifies at least 30 days at each stage before escalation.

What side effects can happen on Foundayo 2.5 mg?

The most common Foundayo side effects are gastrointestinal.

These may include:

• nausea
• diarrhoea
• constipation
• vomiting
• indigestion
• abdominal discomfort

Side effects often become more noticeable when treatment begins or the dose increases.

They may settle as your body adjusts, but persistent or severe symptoms should be reviewed.

What if I don't feel much appetite suppression on 2.5 mg?

That does not necessarily mean Foundayo is not working.

2.5 mg is still relatively early in the dosing pathway.

The aim is not to eliminate normal hunger completely. Treatment should support appetite management while allowing you to eat adequately and maintain a balanced diet.

If you have completed the required time on 2.5 mg and feel that treatment is not providing sufficient benefit, your clinician can review whether moving to 5.5 mg is appropriate.

What if 2.5 mg feels too strong?

This is equally important.

If you are experiencing:

• persistent nausea
• repeated vomiting
• difficulty eating enough
• significant diarrhoea
• severe constipation
• dehydration
• troublesome abdominal symptoms

contact your prescriber before increasing.

Dose escalation should never be treated as more important than tolerability.

How Pharmulous can help

At Pharmulous, we recognise that patients do not all experience dose escalation in exactly the same way.

Our approach is holistic, flexible and patient centred while remaining clinically safe.

We consider:

• how you tolerated 0.8 mg
• appetite and food noise
• your weight trajectory
• side effects
• nutritional intake
• other medication
• your wider medical history
• your overall treatment goals

We do not encourage patients to rush through treatment simply because the next strength is available.

Equally, when it is clinically appropriate to progress, our clinicians can help ensure that dose escalation follows a safe and structured pathway.

Our aim is to support you through each stage rather than treating Foundayo as a simple tick-box dosing schedule.

Frequently Asked Questions

How long do I take Foundayo 2.5 mg?

At least 30 days before moving to 5.5 mg.

What comes after Foundayo 2.5 mg?

The next licensed strength is Foundayo 5.5 mg once daily.

Can I increase before 30 days?

No. The licensed schedule requires at least 30 days at the current dose before increasing.

What if I'm still hungry on 2.5 mg?

This can happen. Appetite response varies, and 2.5 mg remains an early stage of treatment. Discuss your response at your next clinical review.

Should I increase if I still have side effects?

Not without discussing this with your prescriber.

Key Takeaway

Foundayo 2.5 mg is the second stage of the standard dose-escalation pathway.

It gives your body more time to adapt before moving to higher treatment doses.

At Pharmulous, we believe dose progression should remain clinically safe, supported and responsive to the individual patient, rather than being rushed.

References

1. Foundayo (orforglipron) UK Summary of Product Characteristics, electronic Medicines Compendium.
2. Foundayo UK Patient Information Leaflet, electronic Medicines Compendium.
3. Eli Lilly Foundayo dosing information.